Immatics (IMTX) Share-based Compensation (2019 - 2025)

Immatics recorded quarterly Share-based Compensation of $3.8 million in Q4 2025, up 1.48% quarter-over-quarter from $3.8 million in Q3 2025, and down 20.57% year-over-year from $4.8 million in Q4 2024.

Immatics' Share-based Compensation history runs 7 years deep, the most recent figure standing at $3.8 million for Q4 2025.

  • In Q4 2025, Share-based Compensation fell 20.57% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $16.9 million (down 11.63% YoY), while the FY2025 annual figure was $17.0 million, down 10.02% from the prior year.
  • Share-based Compensation came in at $3.8 million for Q4 2025 at Immatics, up from $3.8 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $10.0 million in Q1 2021 to a low of -$17.5 million in Q4 2023.
  • A 5-year average of $4.6 million and a median of $5.3 million in 2021 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation surged 23165.37% in 2021 and tumbled 393.7% in 2023, its largest moves.
  • Immatics' Share-based Compensation stood at $5.4 million in 2021, then gained by 10.16% to $6.0 million in 2022, then sank by 393.7% to -$17.5 million in 2023, then surged by 127.64% to $4.8 million in 2024, then fell by 20.57% to $3.8 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $3.8 million, $3.8 million, and $4.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 892,057.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 305,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 166.40 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 257.40 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 70.15 Mn
10 Immatics 1.80 Bn 1.80 Bn - 3.84 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.84 Mn
Dec 31, 2025 3.84 Mn
Sep 30, 2025 3.79 Mn
Sep 30, 2025 3.79 Mn
Jun 30, 2025 4.69 Mn
Jun 30, 2025 4.69 Mn
Mar 31, 2025 4.55 Mn
Mar 31, 2025 4.55 Mn
Dec 31, 2024 4.84 Mn
Dec 31, 2024 4.84 Mn
Sep 30, 2024 4.95 Mn
Sep 30, 2024 4.95 Mn
Jun 30, 2024 4.64 Mn
Jun 30, 2024 4.64 Mn
Mar 31, 2024 4.67 Mn
Mar 31, 2024 4.67 Mn
Dec 31, 2023 -17.51 Mn
Dec 31, 2023 -17.51 Mn
Sep 30, 2023 5.10 Mn
Sep 30, 2023 5.10 Mn
Jun 30, 2023 6.00 Mn
Jun 30, 2023 6.00 Mn
Mar 31, 2023 6.55 Mn
Mar 31, 2023 6.55 Mn
Dec 31, 2022 5.96 Mn
Dec 31, 2022 5.96 Mn
Sep 30, 2022 5.51 Mn
Sep 30, 2022 5.51 Mn
Jun 30, 2022 5.93 Mn
Jun 30, 2022 5.93 Mn
Mar 31, 2022 6.40 Mn
Mar 31, 2022 6.40 Mn
Dec 31, 2021 5.41 Mn
Dec 31, 2021 5.41 Mn
Sep 30, 2021 6.37 Mn
Sep 30, 2021 6.37 Mn
Jun 30, 2021 9.59 Mn
Jun 30, 2021 9.59 Mn
Mar 31, 2021 10.02 Mn
Mar 31, 2021 10.02 Mn
Dec 31, 2020 -182.11 Mn
Dec 31, 2020 -182.11 Mn
Sep 30, 2020 -178.47 Mn
Sep 30, 2020 -178.47 Mn
Jun 30, 2020 7.59 Mn
Jun 30, 2020 7.59 Mn
Mar 31, 2020 43,053.62
Mar 31, 2020 43,053.62
Dec 31, 2019 39,847.96
Dec 31, 2019 39,847.96
Sep 30, 2019 41,171.01
Sep 30, 2019 41,171.01